Task V30: GMP Manufacturing of WNV Vaccine
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 272201800009I-P00004-759302200001-1
Grant search
Key facts
Disease
Disease XStart & end year
20222026Known Financial Commitments (USD)
$591,316Funder
National Institutes of Health (NIH)Principal Investigator
TIM FOUTSResearch Location
United States of AmericaLead Research Institution
ADVANCED BIOSCIENCE LABORATORIES, INC.Research Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Vaccine logistics and supply chains and distribution strategies
Special Interest Tags
N/A
Study Type
Not applicable
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The Manufacture and Characterization Services (MCS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of services spanning product development planning and feasibility assessments; product optimization; product development and cGMP compliant manufacture for Phase I/II clinical studies; technical and facility audits; and regulatory support appropriate for submission to the U.S. Food and Drug Administration (FDA). These services will facilitate the development and introduction of new vaccines and biologics. This contract also provides for manufacture of vaccines, vaccine components including adjuvants, vaccine delivery systems, other biologics, and challenge material.